Davis Aaron I.

Insider Reports History

Location
San Diego, CA
Signature
/s/ Davis Aaron I.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Davis Aaron I.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Odonate Therapeutics, Inc. Director, 10%+ Owner Common Stock 4,607,086 $7,225,754 $1.57 19 Nov 2021 Indirect
Odonate Therapeutics, Inc. Director, 10%+ Owner Common Stock 445,756 $699,124 $1.57 19 Nov 2021 Direct
Rain Oncology Inc. Director Common Stock, par value $0.001 per share 0 $0 $1.21 26 Jan 2024 Direct
Tango Therapeutics, Inc. Other* Stock Option (Right to Buy) 65,000 03 Sep 2024 Direct
iTeos Therapeutics, Inc. Director Stock Option (Right to Buy) 24,200 11 Jun 2024 Direct
Mirati Therapeutics, Inc. Director Common Stock 0 $59.02 23 Jan 2024 Direct
Mirati Therapeutics, Inc. Director Option to Purchase Common Stock 0 23 Jan 2024 Direct
Rain Oncology Inc. Director Stock Option (Right to Buy) 0 26 Jan 2024 Direct

Insider Reports Filed by Davis Aaron I.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TNGX Tango Therapeutics, Inc. 03 Sep 2024 1 $0 4 Other* 05 Sep 2024, 21:01
ITOS iTeos Therapeutics, Inc. 11 Jun 2024 1 $0 4 Director 13 Jun 2024, 20:00
/report/000199937124000965-davis-aaron-i-2024-01-26 Rain Oncology Inc. 26 Jan 2024 3 $0 4 Director 26 Jan 2024, 16:41
/report/000114036124003538-davis-aaron-i-2024-01-23 Mirati Therapeutics, Inc. 23 Jan 2024 6 $0 4 Director 23 Jan 2024, 20:38
/report/000162828024000357-davis-aaron-i-2023-12-29 Mirati Therapeutics, Inc. 29 Dec 2023 1 +$399,970 4 Director 03 Jan 2024, 20:50
/report/000110465923090698-davis-aaron-i-2023-08-09 Rain Oncology Inc. 09 Aug 2023 1 $0 4 Director 11 Aug 2023, 21:05
ITOS iTeos Therapeutics, Inc. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 19:52
TNGX Tango Therapeutics, Inc. 06 Jun 2023 2 $0 4 Director 08 Jun 2023, 21:32
/report/000121465923001050-davis-aaron-i-2023-01-20 Mirati Therapeutics, Inc. 20 Jan 2023 2 $0 4 Director, 10%+ Owner 24 Jan 2023, 15:20
/report/000089924322035366-davis-aaron-i-2022-11-04 Rain Therapeutics Inc. 04 Nov 2022 2 +$7,999,996 4 Director 08 Nov 2022, 15:30
ITOS iTeos Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 19:47
TNGX Tango Therapeutics, Inc. 08 Jun 2022 1 $0 4 Director 28 Jun 2022, 16:30
/report/000089924322029321-davis-aaron-i-2022-06-01 Rain Therapeutics Inc. 01 Jun 2022 1 $0 4 Director 19 Aug 2022, 17:40
ITOS iTeos Therapeutics, Inc. 09 May 2022 6 -$13,949,234 4 Director 11 May 2022, 21:15
ITOS iTeos Therapeutics, Inc. 28 Apr 2022 5 -$10,247,871 4 Director 02 May 2022, 21:15
ITOS iTeos Therapeutics, Inc. 22 Mar 2022 4 +$1,625,489 4 Director 24 Mar 2022, 21:00
/report/000121465922000842-davis-aaron-i-2022-01-14 Mirati Therapeutics, Inc. 14 Jan 2022 2 $0 4 Director, 10%+ Owner 18 Jan 2022, 17:17
/report/000089924321045438-davis-aaron-i-2021-11-17 Odonate Therapeutics, Inc. 17 Nov 2021 5 -$2,499,948 4 Director, 10%+ Owner 19 Nov 2021, 18:22
ITOS iTeos Therapeutics, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 20:17